BRIEF published on 07/01/2024 at 09:58, 1 year 9 months ago Aquis Stock Exchange: Suspension from Trading Ordinary Shares Aquis Stock Exchange Trading Suspension July 2024 Crushmetric Group Limited
BRIEF published on 07/01/2024 at 09:58, 1 year 9 months ago Bourse Aquis : suspension de la négociation Actions Ordinaires Bourse Aquis Juillet 2024 Groupe Crushmetric Limité Suspension Des Échanges
BRIEF published on 07/01/2024 at 09:56, 1 year 9 months ago Déclaration de franchissement de seuils pour Casino Guichard-Perrachon Capital Droits De Vote Franchissement De Seuil Goldman Sachs Casino Guichard-Perrachon
BRIEF published on 07/01/2024 at 09:56, 1 year 9 months ago Declaration of threshold crossing for Casino Guichard-Perrachon Voting Rights Capital Goldman Sachs Crossing Threshold Guichard-Perrachon Casino
BRIEF published on 07/01/2024 at 09:47, 1 year 9 months ago Study Highlights Benefits of Minimalist Phone App in Reducing Screen Time Productivity Mental Health Screen Time Management Digital Wellness Smartphone Use Reduction
BRIEF published on 07/01/2024 at 09:47, 1 year 9 months ago Une étude met en évidence les avantages de l'application téléphonique minimaliste pour réduire le temps d'écran Santé Mentale Productivité Gestion Du Temps D'écran Bien-être Numérique Réduction De L'utilisation Des Smartphones
BRIEF published on 07/01/2024 at 09:37, 1 year 9 months ago “Hauptstadtkongress 2024”: Medios Hosts Symposium on 'Security of Supply' Healthcare System Medios AG Specialty Pharma Hauptstadtkongress 2024 Security Of Supply
BRIEF published on 07/01/2024 at 09:37, 1 year 9 months ago « Hauptstadtkongress 2024 » : Medios organise un symposium sur la « sécurité d'approvisionnement » Medios AG Pharmacie Spécialisée Congrès De La Hauptstadt 2024 Système De Soins De Santé Sécurité D'approvisionnement
BRIEF published on 07/01/2024 at 09:27, 1 year 9 months ago ABIONYX Successfully Completes €3.4 Million Capital Increase Capital Increase Biotech Shares And Warrants ABIONYX Sepsis Development
BRIEF published on 07/01/2024 at 09:27, 1 year 9 months ago ABIONYX finalise avec succès une augmentation de capital de 3,4 millions d'euros Augmentation De Capital Actions Et Bons De Souscription Biotechnologies ABIONYX Développement De La Septicémie
Published on 04/22/2026 at 13:30, 14 minutes ago ZTEST Electronics Inc. Announces Its Intention to Effect a Normal Course Issuer Bid
Published on 04/22/2026 at 13:00, 44 minutes ago Kalo Gold Defines Kilometre-Scale Epithermal Gold Targets and Structural Corridors at Wainikoro Within a 40 km Gold Corridor, Vatu Aurum, Fiji
Published on 04/22/2026 at 13:00, 44 minutes ago Revolve Accelerates Growth of Distributed Generation Portfolio with Definitive Agreements for 9 New Solar Projects in Mexico
Published on 04/22/2026 at 13:35, 9 minutes ago DeFi Technologies' Asset Management Business, Valour, Secures US$11 Million in Institutional Investment into Hedera ETPs, Including US$10 Million on Börse Frankfurt and US$1 Million on Sweden's Spotlight
Published on 04/22/2026 at 13:05, 39 minutes ago EQS-Adhoc: ad pepper media International N.V.: Strongest first quarter in over 25 years of company history, EBITDA between EUR 6.5 and EUR 7.5 million expected for 2026
Published on 04/22/2026 at 13:00, 44 minutes ago Infosys Announces Strategic Collaboration with OpenAI to Accelerate Enterprise AI Transformation and Unlock AI Value at Scale
Published on 04/22/2026 at 12:55, 48 minutes ago innoscripta SE: Annual General Meeting approves dividend of EUR 4.00 per share and confirms Supervisory Board with strong capital markets expertise
Published on 04/22/2026 at 12:30, 1 hour 13 minutes ago Schaeffler partners with Vietnamese humanoid robot manufacturer VinDynamics
Published on 04/22/2026 at 07:00, 6 hours 44 minutes ago Chiffre d'affaires 1er trimestre 2026. 229,5M€ à devises constantes. 215,5 M€ à devises courantes.
Published on 04/22/2026 at 07:00, 6 hours 44 minutes ago Q1 2026 sales. €229.5m at constant exchange rates. €215.5m at current exchanges rates
Published on 04/21/2026 at 19:15, 18 hours 29 minutes ago AXA - Description of the Company’s share repurchase program
